
StudyFinder
Efficacy/Safety of SPR001 (Tildacerfont) in Adults with Classic Congenital Adrenal Hyperplasia

OPEN TO ACCRUAL
drug: Spr001 (tildacerfont)
Endocrine, Nutritional, Metabolic Diseases, Immunity Disorders (240-279)
Memoli, Erica, H - erica.memoli@vcuhealth.org
Gupta, Anshu
II
HM20019413
NCT04457336
See this study on ClinicalTrials.gov